{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:39:39Z","timestamp":1775147979557,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["D43-TW010345"],"award-info":[{"award-number":["D43-TW010345"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["D43-TW010543"],"award-info":[{"award-number":["D43-TW010543"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00277-020-03908-8","type":"journal-article","created":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T06:02:40Z","timestamp":1579327360000},"page":"571-578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1408-2604","authenticated-orcid":false,"given":"Jessica","family":"Opie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Antel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ania","family":"Koller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Novitzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,18]]},"reference":[{"key":"3908_CR1","doi-asserted-by":"publisher","unstructured":"Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision to the World Health Organization (WHO) classification of lymphoid neoplasms. Blood. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","DOI":"10.1182\/blood-2016-01-643569"},{"key":"3908_CR2","doi-asserted-by":"publisher","unstructured":"Yarchoan R, Uldrick TS (2018) HIV-associated cancers and related diseases. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMra1615896","DOI":"10.1056\/NEJMra1615896"},{"issue":"06","key":"3908_CR3","doi-asserted-by":"publisher","first-page":"530,531","DOI":"10.4236\/jct.2015.66057","volume":"06","author":"M Patel","year":"2015","unstructured":"Patel M, Philip V, Omar T et al (2015) The impact of human immunodeficiency virus infection (HIV) on lymphoma in South Africa. J Cancer Ther 06(06):530,531. https:\/\/doi.org\/10.4236\/jct.2015.66057","journal-title":"J Cancer Ther"},{"issue":"5","key":"3908_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/annonc\/mdv036","volume":"26","author":"SK Barta","year":"2015","unstructured":"Barta SK, Samuel MS, Xue X et al (2015) Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma. Ann Oncol 26(5):958\u2013966. https:\/\/doi.org\/10.1093\/annonc\/mdv036","journal-title":"Ann Oncol"},{"issue":"3","key":"3908_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1200\/JGO.2015.002378","volume":"3","author":"G Sissolak","year":"2017","unstructured":"Sissolak G, Seftel M, Uldrick TS et al (2017) Burkitt\u2019s lymphoma and B-cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt\u2019s lymphoma in patients with HIV: outcomes in a South African public hospital. J Glob Oncol 3(3):218\u2013226. https:\/\/doi.org\/10.1200\/JGO.2015.002378","journal-title":"J Glob Oncol"},{"key":"3908_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1006\/excr.1999.4686","volume":"77","author":"CV Dang","year":"1999","unstructured":"Dang CV, Resar LMS, Emison E et al (1999) Function of the c-Myc oncogenic transcription factor. Exp Cell Res 77:63\u201377","journal-title":"Exp Cell Res"},{"key":"3908_CR7","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/bjh.13501","volume":"170","author":"SM Aukema","year":"2015","unstructured":"Aukema SM, Theil L, Rohde M, Bauer B, Bradtke J, Burkhardt B, Bonn BR, Claviez A, Gattenl\u00f6hner S, Makarova O, Nagel I, Oschlies I, Pott C, Szczepanowski M, Traulsen A, Kluin PM, Klapper W, Siebert R, Murga Penas EM (2015) Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations. Br J Haematol 170:814\u2013825. https:\/\/doi.org\/10.1111\/bjh.13501","journal-title":"Br J Haematol"},{"key":"3908_CR8","unstructured":"Declaration of Helsinki \u2013 Ethical principles for medical research involving human subjects. The World Medical Association. https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/. Accessed September 27, 2019"},{"key":"3908_CR9","unstructured":"Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, Fourth edn. IARC, Lyon"},{"key":"3908_CR10","volume-title":"World Health Organization classification of tumours of haematopoeitic and lymphoid tissues","author":"E Jaffee","year":"2001","unstructured":"Jaffee E, Harris N, VJ SH (2001) World Health Organization classification of tumours of haematopoeitic and lymphoid tissues. IARC Press, Lyon"},{"issue":"1","key":"3908_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/bjh.12736","volume":"165","author":"DA Rizzieri","year":"2014","unstructured":"Rizzieri DA, Johnson JL, Byrd JC, Lozanski G, Blum KA, Powell BL, Shea TC, Nattam S, Hoke E, Cheson BD, Larson RA, Alliance for Clinical Trials In Oncology (ACTION) (2014) Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and leukemia group B study 10 002. Br J Haematol 165(1):102\u2013111. https:\/\/doi.org\/10.1111\/bjh.12736","journal-title":"Br J Haematol"},{"issue":"9","key":"3908_CR12","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/leu.2012.121","volume":"26","author":"JJM Van Dongen","year":"2012","unstructured":"Van Dongen JJM, Orfao A (2012) EuroFlow: resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine. Leukemia. 26(9):1899\u20131907. https:\/\/doi.org\/10.1038\/leu.2012.121","journal-title":"Leukemia."},{"issue":"8","key":"3908_CR13","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","volume":"13","author":"GM Mead","year":"2002","unstructured":"Mead GM, Sydes MR, Walewski J, Grigg A, Hatton CS, Pescosta N, Guarnaccia C, Lewis MS, McKendrick J, Stenning SP, Wright D, UKLG LY06 collaborators (2002) An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt\u2019s lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol 13(8):1264\u20131274. https:\/\/doi.org\/10.1093\/annonc\/mdf253","journal-title":"Ann Oncol"},{"issue":"8","key":"3908_CR14","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1200\/JCO.1999.17.8.2461","volume":"17","author":"DA Thomas","year":"1999","unstructured":"Thomas DA, Cortes J, O\u2019Brien S et al (1999) Hyper-CVAD program in Burkitt\u2019s-type adult acute lymphoblastic leukemia. J Clin Oncol 17(8):2461\u20132470. https:\/\/doi.org\/10.1200\/JCO.1999.17.8.2461","journal-title":"J Clin Oncol"},{"issue":"12","key":"3908_CR15","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/bjc.1998.379","volume":"77","author":"A Atra","year":"1998","unstructured":"Atra A, Gerrard M, Hobson R, Imeson JD, Ashley S, Pinkerton CR (1998) Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin\u2019s lymphoma (B-NHL)--results of the UKCCSG 9003 protocol. Br J Cancer 77(12):2281\u20132285. https:\/\/doi.org\/10.1038\/bjc.1998.379","journal-title":"Br J Cancer"},{"issue":"11","key":"3908_CR16","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3324\/haematol.2013.086827","volume":"98","author":"T Intermesoli","year":"2013","unstructured":"Intermesoli T, Rambaldi A, Rossi G, Delaini F, Romani C, Pogliani EM, Pagani C, Angelucci E, Terruzzi E, Levis A, Cassibba V, Mattei D, Gianfaldoni G, Scattolin AM, di Bona E, Oldani E, Parolini M, G\u00f6kbuget N, Bassan R (2013) High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program. Haematologica. 98(11):1718\u20131725. https:\/\/doi.org\/10.3324\/haematol.2013.086827","journal-title":"Haematologica."},{"issue":"1","key":"3908_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4102\/sajhivmed.v18i1.776","volume":"18","author":"G Meintjes","year":"2017","unstructured":"Meintjes G, Moorhouse MA, Carmona S, Davies N, Dlamini S, van Vuuren C, Manzini T, Mathe M, Moosa Y, Nash J, Nel J, Pakade Y, Woods J, van Zyl G, Conradie F, Venter F (2017) Adult antiretroviral therapy guidelines 2017. South Afr J HIV Med 18(1):1\u201324. https:\/\/doi.org\/10.4102\/sajhivmed.v18i1.776","journal-title":"South Afr J HIV Med"},{"issue":"25","key":"3908_CR18","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1182\/blood-2010-03-275917","volume":"116","author":"M Guech-Ongey","year":"2010","unstructured":"Guech-Ongey M, Simard EP, Anderson WF, Engels EA, Bhatia K, Devesa SS, Mbulaiteye SM (2010) AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and\/or biology? Blood. 116(25):5600\u20135604. https:\/\/doi.org\/10.1182\/blood-2010-03-275917","journal-title":"Blood."},{"key":"3908_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ijlh.12782","volume":"2018","author":"L Phillips","year":"2017","unstructured":"Phillips L (2017) Opie J. The utility of bone marrow sampling in the diagnosis and staging of lymphoma in South Africa 2018:1\u20138. https:\/\/doi.org\/10.1111\/ijlh.12782","journal-title":"The utility of bone marrow sampling in the diagnosis and staging of lymphoma in South Africa"},{"issue":"6","key":"3908_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ajh.23187","volume":"87","author":"SM Mbulaiteye","year":"2012","unstructured":"Mbulaiteye SM, Anderson WF, Ferlay J, Bhatia K, Chang C, Rosenberg PS, Devesa SS, Parkin DM (2012) Pediatric, elderly, and emerging adult-onset peaks in Burkitt\u2019s lymphoma incidence diagnosed in four continents, excluding Africa. Am J Hematol 87(6):573\u2013578. https:\/\/doi.org\/10.1002\/ajh.23187","journal-title":"Am J Hematol"},{"issue":"1","key":"3908_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1309\/AJCP93LJPTRQPDKR","volume":"134","author":"K Kelemen","year":"2010","unstructured":"Kelemen K, Braziel RM, Gatter K, Bakke TC, Olson S, Fan G (2010) Immunophenotypic variations of Burkitt lymphoma. Am J Clin Pathol 134(1):127\u2013138. https:\/\/doi.org\/10.1309\/AJCP93LJPTRQPDKR","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"3908_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/modpathol.2010.76","volume":"23","author":"AC Seegmiller","year":"2010","unstructured":"Seegmiller AC, Garcia R, Huang R, Maleki A, Karandikar NJ, Chen W (2010) Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas. Mod Pathol 23(7):909\u2013920. https:\/\/doi.org\/10.1038\/modpathol.2010.76","journal-title":"Mod Pathol"},{"issue":"6","key":"3908_CR23","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/cncr.11628","volume":"98","author":"ES Wang","year":"2003","unstructured":"Wang ES, Straus DJ, Teruya-Feldstein J, Qin J, Portlock C, Moskowitz C, Goy A, Hedrick E, Zelenetz AD, Noy A (2003) Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate\/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M\/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer. 98(6):1196\u20131205. https:\/\/doi.org\/10.1002\/cncr.11628","journal-title":"Cancer."},{"key":"3908_CR24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-051771","volume-title":"Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma\/leukemia: a prospective study","author":"L Galicier","year":"2007","unstructured":"Galicier L, Fieschi C, Borie R et al (2007) Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma\/leukemia: a prospective study. https:\/\/doi.org\/10.1182\/blood-2006-10-051771"},{"key":"3908_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2015.06.002","volume":"34","author":"L Pantanowitz","year":"2015","unstructured":"Pantanowitz L, Carbone A, Dolcetti R (2015) Microenvironment and HIV-related lymphomagenesis. Semin Cancer Biol 34:52\u201357. https:\/\/doi.org\/10.1016\/j.semcancer.2015.06.002","journal-title":"Semin Cancer Biol"},{"key":"3908_CR26","unstructured":"UNAIDS Data 2017.; 2017. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20170720_Data_book_2017_en.pdf"},{"issue":"1","key":"3908_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12885-019-5586-4","volume":"19","author":"K Antel","year":"2019","unstructured":"Antel K, Levetan C, Mohamed Z, Louw VJ, Oosthuizen J, Maartens G, Verburgh E (2019) The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting. BMC Cancer 19(1):384. https:\/\/doi.org\/10.1186\/s12885-019-5586-4","journal-title":"BMC Cancer"},{"key":"3908_CR28","first-page":"13","volume":"33","author":"S Li","year":"2010","unstructured":"Li S, Bozzo L, Wu Z, Lu W, Romerio F (2010) The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells. New Microbiol 33:13\u201324 http:\/\/www.newmicrobiologica.org\/PUB\/allegati_pdf\/2010\/1\/13.pdf.","journal-title":"New Microbiol"},{"key":"3908_CR29","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1038\/leu.2017.106","volume":"31","author":"D Germini","year":"2017","unstructured":"Germini D, Tsfasman T, Klibi M, el-Amine R, Pichugin A, Iarovaia OV, Bilhou-Nabera C, Subra F, Bou Saada Y, Sukhanova A, Boutboul D, Rapha\u00ebl M, Wiels J, Razin SV, Bury-Mon\u00e9 S, Oksenhendler E, Lipinski M, Vassetzky YS (2017) HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells. Nat Publ Gr 31:2515\u20132522. https:\/\/doi.org\/10.1038\/leu.2017.106","journal-title":"Nat Publ Gr"}],"updated-by":[{"DOI":"10.1007\/s00277-020-03964-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000}}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-03908-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-020-03908-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-03908-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T00:30:33Z","timestamp":1610843433000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-020-03908-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,18]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["3908"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-03908-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00277-020-03964-0","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,18]]},"assertion":[{"value":"1 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The article \u201cIn the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes\u201d.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Human Research Ethics Committee at the University of Cape Town approved the study. All procedures followed were in accordance with institutional and national ethical standards and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was waived in view of the retrospective nature of the study. Confidentiality and anonymity of patient data was maintained throughout.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}